China
Aier Eye Hospital Group to face slower revenue growth in 2025-26: report
Aier Eye Hospital Group to face slower revenue growth in 2025-26: report
Weaker demand for services and economic uncertainties pose key challenges.
China’s digital health sector poised for growth amidst AI developments
However, data security must be upheld.
China’s CRDMO firms gain temporary reprieve with Biosecure act delay
The act’s postponement opens opportunities to expand overseas investment.
China's intraocular lens market to see 2% CAGR until 2033
Its expansion is attributed to the rising prevalence of myopia.
Perennial Holdings operates China’s first wholly foreign-owned tertiary hospital
The 500-bed facility is set to begin operations soon.
Parkway Shanghai unveils new brand positioning and expansion plans
The group plans to open an ambulatory care centre next year.
What factors drive China’s proton therapy market?
China is expanding its network of centres across major cities.
China’s artificial hip and knee joints market to hit $1.01b by 2030
Thanks to a rising incidence of age-related joint disorders.
Mainland China’s pharmaceutical sales to hit $345b by 2033
Global drugmakers seek partnerships to boost their presence in the world's second-largest pharmaceutical market.
Medical equipment, services sectors to benefit from China’s fiscal boost
The Ministry of Finance may issue $142b of special bonds to stimulate consumption.
China emerges as key player in oncology with antibody-drug conjugates surge
It represents 82% of the ADC pipeline in major APAC markets.
China to allow wholly foreign-owned hospitals in select areas
Conditions, requirements, and procedures for set-up will be specified at a later date.
China's LAA closure devices market to grow at 5% CAGR through 2033
The competitive landscape is expected to fuel an increase in research and development investments.
China gains strong foothold in therapeutic cancer vaccines market
Seven cancer vaccines have been approved in the country.
China’s robotic surgical systems market to reach $250m by 2033
The country accounted for approximately 30% of APAC’s market share in 2023.
China’s electrophysiology ablation market CAGR to reach 15% through 2033
Key growth drivers include the advancements in pulsed field technology and the adoption of new products.
China’s NHC issues guidelines for improved critical care medical services
The guidelines aim to provide 15 intensive-care hospital beds by 2025.
Most Read
1. Thomson Medical to open second fertility hub 2. Thomson Medical to provide benefits for Great Eastern Life policyholders 3. Global dermatology market to reach $32.98b by 2029 4. SingHealth and Philips ink MoU to advance digital-first healthcare 5. Singapore to establish new communicable diseases agency in AprilResource Center
Read Here
Advertise
Sign Up
Awards
Apr
10
Events
Event News
She shared how healthcare leaders can balance innovation, governance, and patient outcomes to tackle challenges and drive transformation.
